Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours

Spremljeno u:
Bibliografski detalji
Glavni autori: Koumarianou, Anna, Antoniou, Stavroula, Kanakis, George, Economopoulos, Nikolaos, Rontogianni, Dimitra, Ntavatzikos, Anastasios, Tsavaris, Nikolaos, Pectasides, Dimitrios, Dimitriadis, George, Kaltsas, Gregory
Format: Artigo
Jezik:Inglês
Izdano: Society for Endocrinology 2012
Teme:
Letter to the Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255566/
https://ncbi.nlm.nih.gov/pubmed/22232542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-11-0287
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items